Skip to main content
Clinical Trials/CTRI/2024/06/069550
CTRI/2024/06/069550Active, not recruitingNot Applicable

Evaluation of serum level of Interleukin 4, Interleukin 6 in patients with major depressive disorder considering history of suicide attempts in a tertiary care hospital of Eastern India – A cross sectional study

R G Kar Medical College and Hospital1 site in 1 country41 target enrollmentStarted: July 5, 2024Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
41
Locations
1
Primary Endpoint
To find out the link between serum IL 6, IL 4 and psychosocial variables in suicide attempts

Study Overview

Brief Summary

Patient suffering from Major Depressive Disorder (MDD) with a history of suicide attempts attending the in and outpatient department

of Psychiatry of R G kar Medical College & Hospital, having given proper consent and fulfilling

inclusion and exclusion criteria are taken into the study. Patients will be assessed using Mini International

Neuropsychiatric Interview (M.I.N.I). Depressive symptoms will be evaluated using the Public Health

Questionnaire (PHQ-9), Hamilton Depression Rating Scale (HDRS). Suicide attempts will be

assessed by the Pierce Suicide Intent Scale. Serum IL 4 and IL 6 will be measured by ELISA technique.

Descriptive statistics will be utilized for the expression of data. The P value of< 0.05 will be considered

statistically significant at a 95 confidence interval. All the analysis will be done by using the SPSS version

27, Graphpad prism etc

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patient of age above 18 years suffering from major depressive disorder with a history of suicide attempts.
  • Patients who will give informed consent for the study.

Exclusion Criteria

  • Patients who disagree to give consent.
  • Patients with a history of substance abuse except tobacco and alcohol.
  • Any chronic condition with cognitive dysfunction.
  • Clinical history of systemic autoimmune disease.
  • Patients receiving recent (last week) anti-inflammatory medication.
  • Patients with severe injuries will not be recruited in the first month following suicide attempts (They will not be considered as a recent suicide attempt group).

Outcomes

Primary Outcomes

To find out the link between serum IL 6, IL 4 and psychosocial variables in suicide attempts

Time Frame: Baseline

Secondary Outcomes

  • 1. To enquire for the correlation between serum IL 6, IL 4 and major depressive disorder (MDD)

Investigators

Sponsor
R G Kar Medical College and Hospital
Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Gunjan Gayen

R G Kar Medical College and Hospital

Study Sites (1)

Loading locations...

Similar Trials